| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |